series-c-plus
Stage
3
Investors
About
OM1 provides an AI-driven healthcare outcomes platform and real-world data products, including the PhenOM foundation model, to identify patient phenotypes, predict medical events and enable regulatory-ready observational studies. It licenses enriched longitudinal datasets and offers analytics and consulting for life sciences, providers, and payers.
Explore OM1's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.